Zoetis (ZTS) Share-based Compensation (2012 - 2026)
Zoetis (ZTS) posted quarterly Share-based Compensation of $25.0 million for Q1 2026, up 47.06% year-over-year from $17.0 million in Q1 2025, and up 13.64% quarter-over-quarter from $22.0 million in Q4 2025.
Zoetis (ZTS) Share-based Compensation (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Share-based Compensation for 15 consecutive years, with $25.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 47.06% year-over-year to $25.0 million; the TTM figure through Mar 2026 stood at $91.0 million (up 9.64% YoY), while the FY2025 annual figure was $83.0 million, up 12.16% from the prior year.
- Share-based Compensation rose to $25.0 million in Q1 2026 per ZTS's latest filing, from $22.0 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $41.0 million in Q2 2025 and bottomed at $3.0 million in Q3 2025.
- Historically, Share-based Compensation has averaged $17.9 million across 5 years, with a median of $17.0 million in 2023.
- On a YoY basis, Share-based Compensation climbed as much as 128.57% in 2022 and fell as far as 78.26% in 2022.
- Zoetis' Share-based Compensation stood at $16.0 million in 2022, then advanced by 6.25% to $17.0 million in 2023, then jumped by 105.88% to $35.0 million in 2024, then slumped by 37.14% to $22.0 million in 2025, then advanced by 13.64% to $25.0 million in 2026.
- Business Quant data shows ZTS's Share-based Compensation at $25.0 million in Q1 2026, $22.0 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 31.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.00 Mn |
| Jun 30, 2026 | 26.00 Mn |
| Mar 31, 2026 | 25.00 Mn |
| Mar 31, 2026 | 25.00 Mn |
| Dec 31, 2025 | 22.00 Mn |
| Dec 31, 2025 | 22.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 41.00 Mn |
| Jun 30, 2025 | 41.00 Mn |
| Mar 31, 2025 | 17.00 Mn |
| Mar 31, 2025 | 17.00 Mn |
| Dec 31, 2024 | 35.00 Mn |
| Dec 31, 2024 | 35.00 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Jun 30, 2024 | 18.00 Mn |
| Jun 30, 2024 | 18.00 Mn |
| Mar 31, 2024 | 8.00 Mn |
| Mar 31, 2024 | 8.00 Mn |